These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 11135387)

  • 61. Multisecond oscillations in firing rate in the globus pallidus: synergistic modulation by D1 and D2 dopamine receptors.
    Ruskin DN; Bergstrom DA; Walters JR
    J Pharmacol Exp Ther; 1999 Sep; 290(3):1493-501. PubMed ID: 10454529
    [TBL] [Abstract][Full Text] [Related]  

  • 62. GABA(A) receptors in the nucleus accumbens core modulate turning behavior induced by dopamine receptor stimulation.
    Akiyama G; Ikeda H; Matsuzaki S; Sato M; Moribe S; Koshikawa N
    J Oral Sci; 2003 Dec; 45(4):185-92. PubMed ID: 14763513
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fetal behavior and the dopamine system: activity effects of D1 and D2 receptor manipulations.
    Moody CA; Robinson SR; Spear LP; Smotherman WP
    Pharmacol Biochem Behav; 1993 Apr; 44(4):843-50. PubMed ID: 8097042
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The dopamine D1 receptor antagonist SCH 23390 can exert D1 agonist-like effects on rat nucleus accumbens neurons.
    Wachtel SR; White FJ
    Neurosci Lett; 1995 Oct; 199(1):13-6. PubMed ID: 8584215
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of dopamine D-1 and D-2 receptors on intraocular pressure in conscious rabbits.
    Prünte C; Nuttli I; Markstein R; Kohler C
    J Neural Transm (Vienna); 1997; 104(2-3):111-23. PubMed ID: 9203075
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differential effects of chronic dopamine D1 and D2 receptor agonists on rotational behavior and dopamine receptor binding.
    Engber TM; Marin C; Susel Z; Chase TN
    Eur J Pharmacol; 1993 Jun; 236(3):385-93. PubMed ID: 8102970
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pressure reversed extracellular striatal dopamine decrease produced by D1 receptor agonist SKF 38393, and D2 receptor agonist LY 171555, but failed to change the effect of the activation of both D1 and D2 receptors.
    Abraini JH; Fechtali T; Rostain JC
    Neuroscience; 1992 Sep; 50(2):395-402. PubMed ID: 1359460
    [TBL] [Abstract][Full Text] [Related]  

  • 69. D2 and D1 dopaminergic activity of 7-OH-DPAT.
    Sethy VH; Ellerbrock BR; Fici GJ; Wu H
    Brain Res; 1996 Sep; 733(1):41-5. PubMed ID: 8891246
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Blockade of neurotensin receptors suppresses the dopamine D1/D2 synergism on immediate early gene expression in the rat brain.
    Alonso R; Gnanadicom H; Fréchin N; Fournier M; Le Fur G; Soubrié P
    Eur J Neurosci; 1999 Mar; 11(3):967-74. PubMed ID: 10103090
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Activation of D1 and D2 dopamine receptors inhibits protein kinase C activity in striatal synaptoneurosomes.
    Giambalvo CT; Wagner RL
    J Neurochem; 1994 Jul; 63(1):169-76. PubMed ID: 7911508
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reevaluation of the two-component hypothesis for turning behaviour by manipulating activities in the striatum and the nucleus accumbens of intact rats.
    Saigusa T; Koshikawa N; Kitamura M; Kobayashi M
    Eur J Pharmacol; 1993 Jun; 237(2-3):161-8. PubMed ID: 8103458
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The cannabinoid receptor agonist WIN 55,212-2 reduces D2, but not D1, dopamine receptor-mediated alleviation of akinesia in the reserpine-treated rat model of Parkinson's disease.
    Maneuf YP; Crossman AR; Brotchie JM
    Exp Neurol; 1997 Nov; 148(1):265-70. PubMed ID: 9398468
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dopamine enhances glutamate-induced excitation of rat striatal neurons by cooperative activation of D1 and D2 class receptors.
    Hu XT; White FJ
    Neurosci Lett; 1997 Mar; 224(1):61-5. PubMed ID: 9132692
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Interaction between D2 dopaminergic and glutamatergic excitatory influences on lower urinary tract function in normal and cerebral-infarcted rats.
    Yokoyama O; Yoshiyama M; Namiki M; de Groat WC
    Exp Neurol; 2001 May; 169(1):148-55. PubMed ID: 11312567
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Physiological release of striatal acetylcholine in vivo: modulation by D1 and D2 dopamine receptor subtypes.
    DeBoer P; Abercrombie ED
    J Pharmacol Exp Ther; 1996 May; 277(2):775-83. PubMed ID: 8627558
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Co-administration of dopamine D1 and D2 agonists additively decreases daily food intake, body weight and hypothalamic neuropeptide Y level in rats.
    Kuo DY
    J Biomed Sci; 2002; 9(2):126-32. PubMed ID: 11914579
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Involvement of dopamine D1 and D2 receptors in the rat nucleus accumbens in immunostimulation.
    Devoino LV; Al'perina EL; Gevorgyan MM; Cheido MA
    Neurosci Behav Physiol; 2007 Feb; 37(2):147-51. PubMed ID: 17187206
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors.
    Dahmer MK; Senogles SE
    J Neurochem; 1996 Jan; 66(1):222-32. PubMed ID: 8522958
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.